-The Hindu Kochi: An artificial scarcity of drugs looms large with the new drug pricing regime, slashing prices for 348 essential drugs, set to prevail from July 29. Many retailers who stock medicines for a week are not picking up medicines and are keeping a minimum inventory. Some retailers said distributors were not making medicines available. It has sent medical retail stores into a tizzy about the fate of already available stocks. J.S....
More »SEARCH RESULT
Organised sector share in milk business should rise to 50 per cent: Sharad Pawar
-PTI NEW DELHI: To ensure sufficient supply of milk at affordable rates, Agriculture Minister Sharad Pawar today said there is a need to increase the share of organised sector in milk business to 50 per cent by the end of the current (12th) Five Year Plan in March, 2017. Despite severe drought in some states like Maharashtra this year, milk production has not reduced, thereby providing good supplementary income to farmers and...
More »Food for thought in a mid-day meal tragedy-Amarjeet Sinha
-The Business Standard The tragedy involving the death of children in a Bihar school should reinforce recent efforts to improve the programme, notes Amarjeet Sinha. The sad loss of 23 innocent lives after consuming hot cooked meals in a school in Bihar has rightly shocked and angered people. The highly poisonous pesticide monocrotophos found in children's food and a headmistress overlooking the cook and the children's protests about the oil and not...
More »Who is dividing society on caste lines? SC asks -Dhananjay Mahapatra
-The Times of India NEW DELHI: Finding tension still simmering in Haryana's Mirchpur village more than three years after dalit houses were torched resulting in a handicapped girl and her father getting burnt to death, the Supreme Court on Monday asked the state, "Who is dividing society on caste lines?" The Haryana government's counsel answered, "The powerful and those in power." The question from a bench of Justices G S Singhvi and V...
More »Price control, IP Act & regulatory framework: Revisiting some imp issues about Indian pharma-Ramesh Adige
-The Economic Times Over a year ago, I had written a piece, Quo Vadis, Indian Pharma? (ET, May 11, 2012), in this column. Some key issues were highlighted in the article. Perhaps it is time to revisit the subject and bring out some current issues. Price control: Hurray, the department of pharmaceuticals has come out with a new non-intrusive price control methodology, moving from the cost-based model to the average market price...
More »